glp-1 medications long term side effects Exploring the of Receptor Agonist: To Ensure Its Optimal Positioning Study identifies benefits, risks linked

Pharmacokinetic studies with canagliflozin and empagliflozin also showed an increased drug systemic exposure in patients with impaired liver function

Treatment strategies are often multifactorial and target central ASCVD risk factors including poor glycaemic control, dyslipidaemia, obesity and hypertension

L-carnitine was first discovered in 1905 by Russian chemists Gulewitsch and Krimberg in infusion broth, and its chemical structure was determined in 1927 by Tomita and Senju

Inject fasted or at least 90 minutes post-meal

Toxicity happens when the level of the toxin goes beyond the robustness&of our body's defense against it